National palliative care measures

Table 1 provides an overview of the national palliative care measures.

Table 1: Overview of the national palliative care measures

Objective area	Measure	Baseline value	Latest value	Status	Latest update
Effective	1.1 Physical wellbeing Proportion of palliative care phases for people with life-limiting illnesses for which the distress related to pain improved or remained at a low level after intervention.	71.1% in 2018	70.6% in 2022	No change	23 May 2024 Data for physical wellbeing
Effective	1.2 Psychosocial wellbeing Proportion of palliative care phases for people with life-limiting illnesses for which psychological or spiritual problems improved or remained at a low level after intervention.	80.2% in 2018	79.2% in 2022	Regress	23 May 2024 Data for psychosocial wellbeing
Effective	1.3 Evidence-based care Proportion of specialist palliative care services that met relevant, evidence-based standards.	. .	. .	Status not known yet	Data for this measure will be added when it becomes available.
Safe	2.1 Avoidance of overtreatment Proportion of people with life limiting illnesses who received potentially non-beneficial treatments at the end of life.	8.9% in 2018	8.3% in 2020	Progress	23 May 2024 Data for avoidance of overtreatment
Safe	2.2 Avoidance of accident and injury Proportion of people with life limiting illnesses who experienced a potentially preventable accident or injury.	. .	. .	Status not known yet	Data for this measure will be added when it becomes available.
Appropriate	3.1a Collaborative care Proportion of people with life limiting illnesses who were cared for in their location of preference at the end of life.	. .	. .	Status not known yet	Data for this measure will be added when it becomes available.
Appropriate	3.1b Collaborative care Proportion of Australians with advance care planning documents.	. .	. .	Status not known yet	Data for this measure will be added when it becomes available.
Appropriate	3.2 Carer wellbeing Proportion of palliative care phases for people with life-limiting illnesses for which family or carer problems improved or remained at a low level after intervention.	75.0% in 2018	73.6% in 2022	Regress	23 May 2024 Data for carer wellbeing
Continuous	4.1 Coordinated care Proportion of people with life-limiting illnesses with a potentially preventable hospitalisation in their last 3 months of life.	12.9% in 2018	11.9% in 2020	Progress	23 May 2024 Data for coordinated care
Continuous	4.2a Timely care Proportion of people who received specialist palliative care in the last year of life with first receipt at least 3 months before death.	20.0% in 2018	20.9% in 2020	Progress	23 May 2024 Data for timely care
Continuous	4.2b Timely care Proportion of inpatient unstable palliative care phases that lasted 3 days or less.	76.1% in 2018	80.7% in 2021	Progress	23 May 2024 Data for timely care
Accessible	5.1a Equitable Number of full-time equivalent employed health practitioners in the specialist palliative care workforce, per 100,000 population.	13.2 FTE per 100,000 in 2018	13.7 FTE per 100,000 in 2022	No change	23 May 2024 Data for equitable
Accessible	5.1b Equitable Proportion of people in need of palliative care who received palliative care.	. .	. .	Status not known yet	Data for this measure will be added when it becomes available.
Accessible	5.2 Inclusive Proportion of people accessing palliative care who felt their care was respectful of their cultural beliefs and practices.	. .	. .	Status not known yet	Data for this measure will be added when it becomes available.

. . Not enough data available yet to report on progress.

Status key

Progress	No change	Regress	Status not known yet
Used where there are 2 or more data points, including at least one data point after the start of the Strategy (2018), and the measure is moving in the desired direction, as indicated by statistical testing.	Used where there are 2 or more data points, including at least one data point after the start of the Strategy (2018), and the latest data are similar to the baseline, as indicated by statistical testing.	Used where there are 2 or more data points, including at least one data point after the start of the Strategy (2018), and the measure is not moving in the desired direction, as indicated by statistical testing.	Used when there is not enough data available yet to report on progress.